Adaptin Bio (APTN) Net Equity Issued and Repurchased (2025 - 2026)
Adaptin Bio (APTN) reported Net Equity Issued and Repurchased of $652000.0 for Q1 2026, down 89.42% on a YoY basis from $6.2 million in Q1 2025, and down 89.42% sequentially from $6.2 million in Q1 2025.
Adaptin Bio (APTN) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends
Adaptin Bio (APTN) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $652000.0 in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 652,000.00 |
| Mar 31, 2026 | 652,000.00 |
| Mar 31, 2025 | 6.16 Mn |
| Mar 31, 2025 | 6.16 Mn |